Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

BAFF: a local and systemic target in autoimmune diseases.

Moisini I, Davidson A.

Clin Exp Immunol. 2009 Nov;158(2):155-63. doi: 10.1111/j.1365-2249.2009.04007.x. Review.

2.

The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.

Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F.

Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15. doi: 10.1016/j.cytogfr.2013.04.003. Review.

PMID:
23684423
3.

Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Rickert RC, Jellusova J, Miletic AV.

Immunol Rev. 2011 Nov;244(1):115-33. doi: 10.1111/j.1600-065X.2011.01067.x. Review.

4.

BAFF, APRIL and human B cell disorders.

Tangye SG, Bryant VL, Cuss AK, Good KL.

Semin Immunol. 2006 Oct;18(5):305-17. Review.

PMID:
16916610
5.

[The role of BAFF in autoimmune diseases].

Matsushita T, Sato S.

Nihon Rinsho Meneki Gakkai Kaishi. 2005 Oct;28(5):333-42. Review. Japanese.

6.

Cracking the BAFF code.

Mackay F, Schneider P.

Nat Rev Immunol. 2009 Jul;9(7):491-502. doi: 10.1038/nri2572. Review.

PMID:
19521398
7.

The role of the BAFF/APRIL system on T cell function.

Mackay F, Leung H.

Semin Immunol. 2006 Oct;18(5):284-9. Review.

PMID:
16931039
8.

BAFF, APRIL and their receptors: structure, function and signaling.

Bossen C, Schneider P.

Semin Immunol. 2006 Oct;18(5):263-75. Review.

PMID:
16914324
9.

BAFF inhibition: a new class of drugs for the treatment of autoimmunity.

Liu Z, Davidson A.

Exp Cell Res. 2011 May 15;317(9):1270-7. doi: 10.1016/j.yexcr.2011.02.005. Review.

10.

B cell activating factor, its role in autoimmunity, and targeting in autoimmune diseases.

Krivosikova M, Dallos T, Maslinski W, Buc M.

Bratisl Lek Listy. 2009;110(3):137-45. Review.

PMID:
19507632
11.

[BAFF: A regulatory cytokine of B lymphocytes involved in autoimmunity and lymphoid cancer].

Reyes S LI, León B F, Rozas V MF, González J P, Naves P R.

Rev Med Chil. 2006 Sep;134(9):1175-84. Review. Spanish.

12.

TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.

Mackay F, Schneider P.

Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):263-76. doi: 10.1016/j.cytogfr.2008.04.006. Review.

PMID:
18514565
13.

BAFF and the regulation of B cell survival.

Schneider P, Tschopp J.

Immunol Lett. 2003 Jul 3;88(1):57-62. Review.

PMID:
12853163
14.

The BAFF/APRIL system: an important player in systemic rheumatic diseases.

Mackay F, Sierro F, Grey ST, Gordon TP.

Curr Dir Autoimmun. 2005;8:243-65. Review.

PMID:
15564724
15.

B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.

Mackay F, Silveira PA, Brink R.

Curr Opin Immunol. 2007 Jun;19(3):327-36. Review.

PMID:
17433868
16.

Regulation of B cell self-tolerance by BAFF.

Brink R.

Semin Immunol. 2006 Oct;18(5):276-83. Review.

PMID:
16916609
17.

The BAFF/APRIL system: life beyond B lymphocytes.

Ng LG, Mackay CR, Mackay F.

Mol Immunol. 2005 May;42(7):763-72. Review.

PMID:
15829264
18.

Effect of TACI signaling on humoral immunity and autoimmune diseases.

Zhang Y, Li J, Zhang YM, Zhang XM, Tao J.

J Immunol Res. 2015;2015:247426. doi: 10.1155/2015/247426. Review.

19.

Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus.

Stohl W.

Expert Opin Ther Targets. 2014 Apr;18(4):473-89. doi: 10.1517/14728222.2014.888415. Review.

PMID:
24521424
20.

Supplemental Content

Support Center